Biotechnology

A Computational Framework for Designing Disordered Prot...

Scientists developed a platform, GOOSE, allowing them to design disordered prote...

Spatiotemporal Multiomics Charts Cellular Dynamics of L...

The team integrated high-resolution spatial transcriptomics, single-cell RNA seq...

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and ...

In this episode of GEN's Touching Base, editors discuss business news from Axiom...

Microbiota-Derived Metabolite Enhances HIV Therapy in M...

The metabolite 10-hydroxystearic acid (10-HSA), from Lactiplantibacillus plantar...

Montana’s new “right to try” law can’t come soon enough...

Kris DeVault is desperate. His son, Brody, was born in March 2023. It wasn’t lon...

Montana’s plan to become an experimental medical hub ju...

As of this week in Montana, any biotech company with an experimental drug has a ...

Latigo Reports Positive Phase IIb Data for Non-Opioid A...

LTG-001 achieved the primary endpoint of the Phase IIb LTG-001-010 trial (NCT071...

Elix and University of Vienna Aim to Advance Drug Disco...

Elix and the University of Vienna will partner to bridge the gap between advance...

Celonic and Leukocare Collaborate to Support Complex Bi...

The collaboration brings together Celonic’s expertise in cell line development, ...

Landmark Phase III Trial Finds Cell Therapy Slows Muscl...

A Phase III trial found the donor-derived cell therapy deramiocel slowed arm mus...

Base Editing Strategy Alleviates Huntington’s Disease i...

By precisely altering the huntingtin gene rather than switching it off, an in vi...

Genetic Study of Fibromyalgia Points to Neurological Basis

A GWAS meta-analysis including 2.5 million individuals identified 26 genetic ris...

Sage Inks Licensing Deal with Causaly’s AI Platform Foc...

In a new publishing deal, Causaly and Sage have announced a partnership to bring...

Genome Mining Points to Less Toxic, More Potent Polyene...

The researchers identified Nys34 as a leading candidate after it demonstrated th...

Capsid Experts Hope to Slash the Cost of Gene Therapies

Manufacturing costs for therapies based on adeno-associated viruses (AAV) could ...

Biopharma Hungry for GLP-1 Receptor Agonist Manufacturi...

NIBRT predicts that the market for GLP-1 receptor agonist-based diabetes and obe...